Medications
Resources
Basic InformationMore InformationLatest News
Health Tip: Packing Prescriptions for TravelDrug Errors Peak in July When New Docs StartFDA Warns Consumers Against Swallowing Topical BenadrylStudy Shows Some Anti-Seizure Meds Raise Suicide RiskU.S. Oftalmi Recalls Camolyn Eye Drops, Fisiolin Nasal DropsPrescriptions Translated to Spanish Could Be Hazardous to HealthTougher-to-Abuse Form of OxyContin ApprovedVaccines-By-Patch Good News for Needle-PhobicRifaximin Maintains Remission in Patients With Liver DiseaseMenstrual Cramps May Be Helped by New DrugNew Inhaled Insulin Shows Promise for DiabetesPlavix Can Help Cut Death Risk in Certain Heart PatientsFDA Asks Docs to Suspend Using Glaxo Rotavirus VaccineFDA Says High-Dose Simvastatin Ups Myopathy RiskHigh-Dose Zocor Boosts Muscle Injury Risk: FDAAvandia Researchers' Financial Ties QuestionedCarbaglu Approved for Rare Genetic DisorderACC: New Dual-Acting Drug Lowers Blood PressureNewer Blood Thinner Beats Plavix for Bypass PatientsArthritis Drug May Fight Diabetes, Too2 Drugs Fail to Prevent Diabetes in the OverweightFDA Adds Boxed Warning to Clopidogrel LabelThiazolidinediones Not Linked to Diabetic Macular EdemaYoung Kids to Benefit From Broader Pneumococcal VaccineBleeding Alert Sounded for Stroke DrugsHeartburn Drug Kapidex Renamed to DexilantLink Between Diabetes and Neuroleptic Drugs OutlinedResistance Likely to Develop With New Hepatitis C DrugsLasofoxifene Examined in Postmenopausal WomenSuccessor to Combination Pneumococcal Vaccine ApprovedMenveo Vaccine Approved for Bacterial MeningitisFDA: No Decision on Whether to Pull Diabetes Drug Avandia Off the MarketRituxan Approved for Chronic Lymphocytic LeukemiaNew Technology Could Widen Reach of VaccinesFDA Issues Warning on Key Asthma DrugsFDA Issues Maalox Total Relief WarningIbuprofen May Help Stave Off Parkinson'sFDA Tightens Controls on Anemia DrugsAdded Drug Aids MS Treatment'Fishy Smell' May Keep Patients From Diabetes DrugBotox May Prevent Some MigrainesAnother Study Refutes Vaccination-Autism LinkCrestor Approval ExpandedParoxetine May Compromise the Efficacy of TamoxifenNeedle Length May Affect Vaccination Results in ObeseDrug May Ease Cognitive Effects of Huntington'sGlaucoma Drugs May Play Role in Longer LifeH1N1 Vaccination Still Highly RecommendedThe Lancet Retracts Study Linking MMR Vaccine, AutismXiaflex Approved for Rare Hand Condition
Questions and AnswersLinksBook Reviews
Related Topics

Anxiety Disorders
Depression: Major Depression & Unipolar Varieties
Medical Disorders
Mental Disorders
Mental Health Professions

As Swine Flu Wanes, So Does Public's Fear

HealthDay News
by By Steven ReinbergHealthDay Reporter
Updated: Dec 22nd 2009

 

new article illustration

TUESDAY, Dec. 22 (HealthDay News) -- The good news on the H1N1 swine flu front is that the number of cases of infection continues to decrease and the vaccine supply is now plentiful.

The discouraging news is that too few people are getting inoculated, a top U.S. health official said Tuesday.

"The H1N1 vaccine supply is getting better and better," Dr. Anne Schuchat, director of the U.S. Centers for Disease Control and Prevention's National Center for Immunization and Respiratory Diseases, said during an afternoon press conference.

While cases of swine flu infection continue to diminish around the country, the H1N1 virus is still the dominant flu strain, Schuchat said. "Disease is at a better state around the country, less virus is circulating," she said. "But still everything we are seeing in terms of the flu strains is the H1N1 virus. So it's not gone at all."

There's no way to predict whether there will be a resurgence of swine flu, which peaked nationwide in early November with 48 states reporting widespread activity.

So, "it is important to not become complacent about the ongoing risk of H1N1 influenza," Schuchat stated.

Schuchat said an estimated 111 million doses of H1N1 vaccine have been distributed so far. A CDC survey done two weeks ago found that about 46 million people had received the vaccine, with approximately 40 percent of the doses going to children, she said.

"Coverage was about twice as high in children as it was in adults," she said. "That's really good news because usually with seasonal flu there's a lot more vaccination of adults, including seniors, than children. But with the H1N1 vaccine we were targeting children because they have been so hard hit by the virus."

Unlike seasonal flu, which typically poses a much bigger threat to people aged 65 and older, the swine flu has been targeting children and young adults, probably because they have little or no immunity to the H1N1 virus, which was last seen on a pandemic level more than 50 years ago.

In a possible response to the drop in swine flu cases nationwide, a new Harvard poll found that only 40 percent of those surveyed were concerned that they or their family would come down with the flu. In a September poll, 52 percent were worried.

The poll also found that by Dec. 17, about 56 million people -- more likely children than adults -- had received the H1N1 vaccine.

"Taking those two data points together, we think right now probably at least 60 million people have been vaccinated with the H1N1 vaccine," Schuchat said.

Now is a good time to get vaccinated against the H1N1 flu, she said, because supplies are plentiful. And should there be another wave of illness, you'd be protected.

Schuchat also said that children under 10 years of age should get two doses of the vaccine to be fully protected. A recent article in the Journal of the American Medical Association suggested that children might need only one dose.

"If you have children who are under 10 years of age that have gotten the H1N1 vaccine, it is important to know that your child needs a second dose," she said. "We recommend two doses of H1N1 vaccine about one month apart."

According to CDC estimates, children and young adults continue to be most vulnerable to the H1N1 flu. From mid-April, when the virus first surfaced, until November, 47 million Americans came down with the swine flu. About 16 million of those people were children under 18 years of age, and about 27 million were adults between 18 and 64.

During the same period, an estimated 9,820 people died, including 1,090 children aged 17 and younger, as well as 7,450 people aged 18 to 64, according to the CDC.

More information

For more on H1N1 swine flu, visit the U.S. Department of Health and Human Services.




To Access Services
Call (815) 224-1610
24 hours a day
7 days a week

info@ncbhs.org

Outpatient Center Locations in Illinois:

  • LaSalle
  • Ottawa
  • Streator
  • Princeton
  • Canton
  • Macomb

powered by centersite dot net